Warning letter
Moore's Pharmacy Inc: warning letter of Jan 16, 2018
FDA warning letter 544530 · Dallas District Office
Key facts
| Reference number | 544530 |
|---|---|
| Company | Moore's Pharmacy Inc |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Jan 16, 2018 |
| Posted date | Jun 19, 2018 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| CFR sections cited | 211.56(a), 211.137(a), 211.192, 200.10(b), 210.1(b) |
| Inspection city | Sinton |
| Inspection ZIP | 78387 |
| Inspection start date | Aug 25, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: